Target intelligence / Profile preview

Ribosomal protein L27a pseudogene 3 (RPL27AP3)

Target
RPL27AP3
Molecular classification
Other (classified as a processed pseudogene, not a protein-coding gene)
01

Overview

Ribosomal protein L27a pseudogene 3 (RPL27AP3) is a processed pseudogene in the human genome, corresponding to the ribosomal protein L27a gene but lacking protein-coding capacity. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they do not produce functional proteins due to critical sequence disruptions such as mutations, deletions, or premature stop codons. RPL27AP3 resides on chromosome 2 and is one of several processed pseudogenes derived from the functional ribosomal protein L27a gene. There is no evidence that RPL27AP3 is transcribed to produce a functional protein or has a role as a therapeutic target, or that it participates in normal ribosomal function or disease processes. RPL27AP3 is a pseudogene, not a coding gene. It does not serve as a therapeutic target or encode a protein product. There are no drugs, biomarkers, or mechanisms of action associated with this pseudogene. It is included in genome databases mainly for reference and annotation, not for a biological function or therapeutic use. If you intended the functional ribosomal protein L27a (RPL27A), refer specifically to "Ribosomal protein L27a" (RPL27A), as this is a separate, coding entity involved in ribosome structure and function.

Other names
RPL27A_1_302RPL27AP3
02

Biological functions

Other (no proven coding function; does not encode a functional ribosomal protein; processed pseudogenes generally lack biological activity)
03

Disease associations

Other (no direct disease association; no known roles as disease-causing or modifying locus)

Beyond the preview

Go deeper on Ribosomal protein L27a pseudogene 3 (RPL27AP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L27a pseudogene 3 (RPL27AP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call